Michael P. Malter
Kerpener Str. 62
Koeln, NW 50937, Germany
Koeln, NW 50937, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 Patients.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: September 15, 2025
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2.
Journal: Journal of neurology
Published: December 09, 2024
Serum NfL predicts outcome and secondary autoimmunity in herpes-simplex encephalitis.
Journal: Journal of neuroimmunology
Published: August 16, 2024
Different pain phenotypes are associated with anti-Caspr2 autoantibodies.
Journal: Journal of neurology
Published: December 12, 2023
Prognosis and management of acute symptomatic seizures: a prospective, multicenter, observational study.
Journal: Annals of intensive care
Published: May 22, 2023
Status epilepticus and benzodiazepine treatment: Use, underdosing and outcome - insights from a retrospective, multicentre registry.
Journal: Seizure
Published: February 18, 2023
Prehospital Levetiracetam Use in Adults With Status Epilepticus: Results of a Multicenter Registry.
Journal: Journal of clinical neurology (Seoul, Korea)
Published: August 16, 2022
Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response.
Journal: Journal of the neurological sciences
Published: June 02, 2022
Seizure Semiology in Antibody-Associated Autoimmune Encephalitis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 02, 2022
Last Updated: 09/26/2026